-
Are physicians in your ED skeptical about the use of thrombolytics for stroke patients? If so, this may soon change, as a result of new recommendations from the Northbrook, IL-based American College of Chest Physicians (ACCP).
-
If a patient comes to your ED with multiple rib fractures after a fall, would you be worried that the injury is life-threatening? The answer largely will depend on the patients age, says Kathleen Emde, RN, CCRN, CEN, trauma service coordinator at Overlake Hospital Medical Center in Bellevue, WA.
-
Although ED nurses at Towson, MD-based St. Joseph Medical Center had treated two flu-related cases as of press time, neither patient had the flu. The story underscores what most ED nurses are anticipating: Due to a shortage of the flu vaccine, this flu season is going to be anything but ordinary.
-
Investigators analyzing data obtained from at-risk populations in the Western United States found a decline in HIV infection between 1989 and 1999, a new study shows.
-
Research often has looked at the way sexually transmitted diseases (STDs) increase the risk of people acquiring HIV, but few have examined the reverse: whether HIV infection increases the risk of acquiring STD.
-
Researchers at the Centers for Disease Control and Prevention (CDC) have concluded that safe sex messages continue to be ignored by many high-risk individuals.
-
-
-
Breast tissue density, as determined by mammography, is known to be a risk factor for the development of invasive breast cancer. In the current analysis of a subgroup of patients participating in the NSABP B-17 trial, those women with highly dense breast tissue were found to have significantly more subsequent breast cancer. Thus, a quantitative assessment of breast density may prove useful in assessment of additional breast cancer risk for patients having breast-conserving surgery for DCIS.
-
Fit elderly patients benefit at least to the same extent from palliative chemotherapy with 5-FU as younger patients. Infusional 5-FU was shown to be more effective than bolus 5-FU in both age groups. Therefore, standardized palliative chemotherapy should generally be offered to elderly patients and they should not be excluded from clinical trials.
